$RSCZF Resinco Capital Partners Inc. (OTC: RSCZF) (CSE: RIN), has been developing a new concept: that the body's own stem cells that induce repair of tissues can be made to function more efficiently. This is very exciting and is something that could really shake up the medical arena.
Over the years, research after research has shown that marijuana is beneficial in the treatment of many conditions which include cancer, multiple sclerosis, epilepsy, arthritis, anxiety, IBS, and PTSD.
Epidiolex, the very first FDA-approved cannabis-based drug just became available in the U.S. at the start of November. When it gained FDA approval this past summer, it was a validation that the world is now ready for cannabinoid medicine.